Usefulness of screening for congenital or acquired hemostatic abnormalities in women with previous complicated pregnancies

Haemostasis

Volumn 29, Issue 4, 1999, Pages 197-203

  Mello, Giorgio ^a   Parretti, Elena ^a   Martini, Elisabetta ^a   Mecacci, Federico ^a   La Torre, Pasquale ^a   Cioni, Riccardo ^a   Lucchetti, Roberto ^a   Fedi, Sandra ^a   Gori, Anna Maria ^a   Pepe, Guglielmina ^a   Prisco, Domenico ^a   Abbate, Rosanna ^a  

^a NONE

Author keywords

Activated protein C resistance; Factor V Leiden; Fetal loss; Preeclampsia

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5; PHOSPHOLIPID ANTIBODY;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FETUS WASTAGE; GENE MUTATION; GENETIC SCREENING; HEMATOLOGIC DISEASE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RISK FACTOR;

EID: 0343049152     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022502     Document Type: Article

References (18)

1. Rai RS, Regan L, Chitolie A, Donald JG, Cohen H: Placental thrombosis and second trimester miscarriage in association with activated protein C resistance. Br J Obstet Gynaecol 1996;103:842-844.
2. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-67.
3. Cumming AM, Tait RC, Fildes S, Yoong A, Keeney S, Hay CRM: Development of resistance to activated protein C during pregnancy. Br J Haematol 1995;90:725-727.
4. Rai RS, Regan L, Dave M, Cohe H: Second-trimester pregnancy loss is associated with activated protein C resistance. Br J Haematol 1996;92: 489-490.
5. Lindoff C, Ingemarsson I, Martinsson G, Segelmark M, Thysell H, Astedt B: Preeclampsia is associated with a reduced response to activated protein C. Am J Obstet Gynecol 1997;176:457-460.
6. Grandone E, Margaglione M, Colaizzo D, d'Addedda M, Cappucci G, Vecchione G, Scianname N, Pavone G, Di Minno G: Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 1997;77:822-824.
7. Dekker GA, de Vries JIP, Doelitzsch PM, Huijgens PC, von Blomberg BME, Jakob SC, van Geijn BP: Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995;173: 1042-1048.
8. Dizon-Townson DS, Meline L, Nelson LM, Varner M, Ward K: Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol 1997;177:402-405.
9. Silver RM, Branch DW: Recurrent miscarriage: Autoimmune considerations. Clin Obstet Gynecol 1994; 37:745-760.
10. Davey DA, McGillivray I: The classification and definition of hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988;158:892-898.
11. Dahlbäck B, Carlsson M, Svensson PJ: Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993;90:1004-1008.
12. Pepe G, Rickards O. Camacjo Vanegas O, Brunelli T, Gori AM, Giusti B, Attanasio M, Frisco D, Gensini GF, Abbate R: Prevalence of factor V Leiden mutation in non-European populations. Thromb Haemost 1997;77:329-331.
13. Abildgaard U, Gravem K, Godal HC: Assay of progressive antithrombin in plasma. Thromb Diath Haemorrh 1970;24:224-229.
14. Martinoli JL, Stocker K: Fast functional C assay using PROTAC, a novel protein C activator. Thromb Res 1986;43:253-264.
15. Suzuki K, Nisiroka J: Plasma protein S activity measuring using PROTAC, a snake venom derived activator of protein C. Thromb Res 1988;49:241-251.
16. Boddi M, Frisco D, Fedi S, Cellai AP, Liotta AA, Parretti E, Mecacci F, Mello G, Abbate R: Antiphospholipid antibodies and pregnancy disorders in women with insulin dependent diabetes. Thromb Res 1996;82:207-216.
17. Dizon-Townson DS, Nelson LK, Easton K, Ward K: The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 1996;175:902-905.
18. Middeldorp S, Henkens CMA, Koopman MMW, van Pampus ECM, Hamulyak K, van der Meer J, Prins MFF, Buller HR: The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis. Ann Intern Med 1998;128:15-20.